Metropolitan Life Insurance Company (MetLife)’s Leggett & Platt LEG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-23,855
| Closed | -$982K | – | 2487 |
|
|
2021
Q4 | $982K | Buy |
23,855
+8,186
| +52% | +$356K | 0.01% | 976 |
|
|
2021
Q3 | $703K | Sell |
15,669
-525
| -3% | -$25.3K | 0.01% | 1212 |
|
|
2021
Q2 | $839K | Sell |
16,194
-209
| -1% | -$10.9K | 0.01% | 1149 |
|
|
2021
Q1 | $749K | Sell |
16,403
-756
| -4% | -$33.6K | 0.01% | 1148 |
|
|
2020
Q4 | $760K | Sell |
17,159
-634
| -4% | -$27.2K | 0.01% | 1081 |
|
|
2020
Q3 | $733K | Sell |
17,793
-788
| -4% | -$31.3K | 0.01% | 930 |
|
|
2020
Q2 | $653K | Sell |
18,581
-1,062
| -5% | -$32.9K | 0.01% | 1024 |
|
|
2020
Q1 | $524K | Sell |
19,643
-76
| -0.4% | -$3.16K | 0.01% | 1018 |
|
|
2019
Q4 | $1M | Sell |
19,719
-185
| -0.9% | -$9.07K | 0.02% | 898 |
|
|
2019
Q3 | $815K | Buy |
19,904
+90
| +0.5% | +$3.53K | 0.01% | 980 |
|
|
2019
Q2 | $760K | Buy |
19,814
+1,272
| +7% | +$50.2K | 0.01% | 1055 |
|
|
2019
Q1 | $783K | Sell |
18,542
-418
| -2% | -$17.6K | 0.01% | 1021 |
|
|
2018
Q4 | $680K | Sell |
18,960
-41
| -0.2% | -$1.56K | 0.01% | 1021 |
|
|
2018
Q3 | $832K | Sell |
19,001
-853
| -4% | -$38.4K | 0.01% | 1035 |
|
|
2018
Q2 | $886K | Sell |
19,854
-5,604
| -22% | -$241K | 0.01% | 979 |
|
|
2018
Q1 | $1.13M | Buy |
25,458
+175
| +0.7% | +$8.02K | 0.02% | 846 |
|
|
2017
Q4 | $1.21M | Sell |
25,283
-42,091
| -62% | -$1.99M | 0.02% | 806 |
|
|
2017
Q3 | $3.22M | Sell |
67,374
-1,036
| -2% | -$50.1K | 0.02% | 795 |
|
|
2017
Q2 | $3.59M | Sell |
68,410
-3,010
| -4% | -$157K | 0.02% | 744 |
|
|
2017
Q1 | $3.59M | Sell |
71,420
-971
| -1% | -$47.4K | 0.02% | 744 |
|
|
2016
Q4 | $3.54M | Sell |
72,391
-1,973
| -3% | -$93.8K | 0.03% | 746 |
|
|
2016
Q3 | $3.39M | Sell |
74,364
-1,234
| -2% | -$63.4K | 0.02% | 743 |
|
|
2016
Q2 | $3.86M | Sell |
75,598
-1,793
| -2% | -$88.3K | 0.03% | 659 |
|
|
2016
Q1 | $3.75M | Sell |
77,391
-1,417
| -2% | -$61.4K | 0.03% | 650 |
|
|
2015
Q4 | $3.31M | Sell |
78,808
-872
| -1% | -$38.7K | 0.03% | 685 |
|
|
2015
Q3 | $3.29M | Sell |
79,680
-1,870
| -2% | -$87.3K | 0.02% | 701 |
|
|
2015
Q2 | $3.97M | Buy |
81,550
+3,053
| +4% | +$143K | 0.03% | 659 |
|
|
2015
Q1 | $3.62M | Sell |
78,497
-640
| -0.8% | -$28.5K | 0.03% | 668 |
|
|
2014
Q4 | $3.37M | Sell |
79,137
-2,241
| -3% | -$88.3K | 0.02% | 724 |
|
|
2014
Q3 | $2.84M | Sell |
81,378
-1,995
| -2% | -$68.4K | 0.02% | 784 |
|
|
2014
Q2 | $2.86M | Sell |
83,373
-1,503
| -2% | -$50.1K | 0.02% | 827 |
|
|
2014
Q1 | $2.77M | Sell |
84,876
-2,664
| -3% | -$82.5K | 0.02% | 817 |
|
|
2013
Q4 | $2.71M | Sell |
87,540
-118
| -0.1% | -$3.52K | 0.02% | 816 |
|
|
2013
Q3 | $2.64M | Sell |
87,658
-998
| -1% | -$30.7K | 0.02% | 786 |
|
|
2013
Q2 | $2.76M | Buy |
+88,656
| New | +$2.89M | 0.02% | 721 |
|
Other funds holding LEG
EIP
Metropolitan Life Insurance Company (MetLife)'s LEG Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Leggett & Platt (LEG) in Q1 2022, closing a stake of 23,855 shares — an estimated $982K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in LEG in Q2 2013 and held it in 35 quarters. The position peaked at $3.97M in Q2 2015. 444 funds tracked by Wall St. Rank hold LEG as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Leggett & Platt position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 23,855 Leggett & Platt shares in Q1 2022, an estimated $982K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Leggett & Platt in Q2 2013 and held it in 35 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Leggett & Platt position peaked at $3.97M in Q2 2015.
- 444 funds tracked by Wall St. Rank held Leggett & Platt as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.